Group One Trading
ZYME icon

Group One Trading’s Zymeworks ZYME Stock Holding History

Group One Trading’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.2K Sell
3,800
-2,800
-42% -$66.2K ﹤0.01% 4781
2025
Q4 		$174K Sell
6,600
-23,100
-78% -$504K ﹤0.01% 4505
2025
Q3 		$507K Buy
29,700
+24,000
+421% +$344K ﹤0.01% 3691
2025
Q2 		$71.5K Buy
5,700
+500
+10% +$5.96K ﹤0.01% 5264
2025
Q1 		$61.9K Sell
5,200
-600
-10% -$8.18K ﹤0.01% 4985
2024
Q4 		$84.9K Sell
5,800
-4,300
-43% -$60.1K ﹤0.01% 4649
2024
Q3 		$127K Buy
10,100
+9,300
+1,163% +$101K ﹤0.01% 3986
2024
Q2 		$6.81K Sell
800
-16,300
-95% -$145K ﹤0.01% 5825
2024
Q1 		$180K Sell
17,100
-47,000
-73% -$522K ﹤0.01% 3647
2023
Q4 		$666K Buy
64,100
+22,800
+55% +$182K ﹤0.01% 2828
2023
Q3 		$262K Buy
41,300
+5,000
+14% +$36.9K ﹤0.01% 3571
2023
Q2 		$314K Sell
36,300
-3,300
-8% -$29.5K ﹤0.01% 3503
2023
Q1 		$358K Buy
39,600
+29,400
+288% +$256K ﹤0.01% 3090
2022
Q4 		$80.2K Sell
10,200
-200
-2% -$1.41K ﹤0.01% 4633
2022
Q3 		$64K Buy
10,400
+10,300
+10,300% +$62.1K ﹤0.01% 5205
2022
Q2 		$1K Buy
+100
New +$605 ﹤0.01% 7644
2022
Q1 		– Sell
-600
Closed -$10K – 8835
2021
Q4 		$10K Sell
600
-11,200
-95% -$234K ﹤0.01% 7363
2021
Q3 		$343K Buy
11,800
+10,400
+743% +$346K ﹤0.01% 4602
2021
Q2 		$49K Sell
1,400
-11,100
-89% -$352K ﹤0.01% 6600
2021
Q1 		$395K Buy
12,500
+5,300
+74% +$215K ﹤0.01% 4310
2020
Q4 		$340K Sell
7,200
-5,500
-43% -$255K ﹤0.01% 3618
2020
Q3 		$592K Buy
12,700
+2,100
+20% +$72.1K ﹤0.01% 2695
2020
Q2 		$382K Sell
10,600
-19,400
-65% -$715K ﹤0.01% 2852
2020
Q1 		$1.06M Buy
30,000
+18,700
+165% +$765K 0.01% 1475
2019
Q4 		$514K Buy
11,300
+800
+8% +$29.1K ﹤0.01% 2413
2019
Q3 		$260K Buy
10,500
+9,800
+1,400% +$246K ﹤0.01% 2893
2019
Q2 		$15K Buy
700
+600
+600% +$11K ﹤0.01% 4290
2019
Q1 		$2K Sell
100
-100
-50% -$1.55K ﹤0.01% 4610
2018
Q4 		$3K Buy
+200
New +$2.62K ﹤0.01% 4602

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Group One Trading's ZYME Position: Q1 2026 in Review

Group One Trading sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 8,841 shares — an estimated $209K sold.

Group One Trading first reported a position in ZYME in Q2 2019 and held it in 20 quarters. The position peaked at $529K in Q1 2022. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Group One Trading reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 8,841 Zymeworks shares in Q1 2026, an estimated $209K.
  • Group One Trading first reported a position in Zymeworks in Q2 2019 and held it in 20 quarters.
  • Group One Trading's Zymeworks position peaked at $529K in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.